Patents for A61P 15 - Drugs for genital or sexual disorders; Contraceptives (55,635)
09/2007
09/05/2007CN101028384A Medicinal composition for treating gynaecologic phlogosis, its production and quality controlling method
09/05/2007CN101028378A Health-care product for improving sexual function
09/05/2007CN101028377A Health-care product for improving sexual function
09/05/2007CN101028376A Chinese medicinal preparation for treating habitual abortion
09/05/2007CN101028369A Chinese medicine for treating impotence
09/05/2007CN101028356A Antiseptic anti-inflammatory and its production
09/05/2007CN101028344A Medicinal composition with corydalis and Radix Angelicae pubescentis, its production and use
09/05/2007CN101028342A Health-care product for improving sexual function
09/05/2007CN101028339A Chinese medicine for treating gynecopathy
09/05/2007CN101028289A Probiotics preparation for adjusting microbial pool, preventing or treating bacterial vaginosis
09/05/2007CN101028288A Membrane-strengthening agent
09/05/2007CN101028261A Use of casticin in preparation of medicine against premenstrual syndrome
09/05/2007CN101028088A Health-care food with sexual-function improving function
09/05/2007CN101028087A Health-care food with sexual-function improving function
09/05/2007CN101028053A Preparing and preserving method for Wubao liquid
09/05/2007CN100335479C Bicyclic inhibitors of glycogen synthase kinase 3
09/05/2007CN100335126C Preparation for preventing and curing endometritis for dairy cattle and preparing method thereof
09/05/2007CN100335104C Health protection capsule suitable for climateric woman
09/05/2007CN100335101C Dysmenorrhea treating medicine
09/05/2007CN100335084C Compound Chinese medicine for treating leukoplakia vulvae and its preparation method
09/05/2007CN100335058C Composition and tablet of mifepristone and anorethidrane dipropionate
09/04/2007US7265157 Sustained release compositions, process for producing the same and use thereof
09/04/2007US7265146 Administering small molecule compounds, especially acids or esters, that inhibit the interaction between alpha 4 integrins and ligands MAdCAM and/or VCAM for treatment of chronic inflammatory diseases such as arthritis, asthma, multiple sclerosis, Chrohn's disease, ulcerative colitis, and hepatitis C
09/04/2007US7265113 Anticancer agents; antiinflammatory agents, for therapy of rheumatoid arthritis
09/04/2007US7264798 Sensitization of chemotherapeutic agent resistant neoplastic cells with a virus
09/04/2007CA2297911C Substituted 6-phenylphenanthridines
08/2007
08/30/2007WO2007098386A1 Pyrazolylquinazolinones as potassium channel openers
08/30/2007WO2007098384A2 Tetracyclic steroid derivatives useful as progesterone receptor modulators
08/30/2007WO2007097707A1 Use of cyclolignans for the treatment of type 2 diabetes and as contraceptives
08/30/2007WO2007096931A2 Use of piperacillin in topical intravaginal preparations for the treatment of vaginal bacterial infections
08/30/2007WO2007096186A1 Substituted phenylpiperidine derivatives as melanocortin-4 receptor modulators
08/30/2007WO2007095830A1 Powder perfusion agent used in the treatment of bovine mastitis and its preparing process
08/30/2007WO2007054279A3 Cyclic-dinucleotides and its conjugates as adjuvants and their uses in pharmaceutical compositions
08/30/2007US20070203353 Bipolar trans carotenoid salts and their uses
08/30/2007US20070203338 2-((4,6-dimethoxy)pyrimidin-2-yl-),3-(methoxy-), 3,3-(diphenyl)propionic acid; antihypotensive agents; pulmonary hypertension, mycocardial necrosis; renal failure; brain disorders; antispasmodic agents; antiischemic agents; coagulants; asthma; atherosclerosis; restenosis; Raynaud's syndrome
08/30/2007US20070203184 Novel Indolin-2-one Derivatives, Their Preparation and the Pharmaceutical Compositions Comprising Them
08/30/2007US20070203152 Low hygroscopic aripiprazole drug substance and processes for the preparation thereof
08/30/2007US20070203151 Low hygroscopic aripiprazole drug substance and processes for the preparation thereof
08/30/2007US20070203150 Low hygroscopic aripiprazole drug substance and processes for the preparation thereof
08/30/2007US20070203141 Method for administering birb 796 bs
08/30/2007US20070202181 Low hygroscopic aripipazole drug substance and processes for the preparation thereof
08/30/2007US20070202160 Solid-state form of celecoxib having enhanced bioavailability
08/30/2007US20070202100 Using programmed death-1 (PD-1) protein as evaluative tool to identify modulators for treatment and prevention of nervous system, autoimmune, cell proliferative and allergic disorders
08/30/2007US20070202099 Antibody Drug
08/30/2007DE212007000001U1 Kombinationspräparat zur Verbesserung der Samenqualität Combination product for improving sperm quality
08/30/2007DE102007016516A1 Arzneimittelzubereitung The pharmaceutical preparation
08/30/2007CA2642832A1 Pyrazolylquinazolinones as potassium channel openers
08/30/2007CA2642763A1 Tetracyclic steroid derivatives useful as progesterone receptor modulators
08/30/2007CA2638124A1 Use of cyclolignans for the treatment of type 2 diabetes and as contraceptives
08/29/2007EP1826201A1 Substituted phenylpiperidine derivatives as melanocortin-4 receptor modulators
08/29/2007EP1824500A1 Probiotic lactobacillus strains for improved vaginal health
08/29/2007EP1824494A1 Topical drug delivery system
08/29/2007EP1450813B1 Antagonists of prostaglandin receptors ep2 and/or ep4 for the treatment of menorrhagia
08/29/2007EP1425019B1 Pharmaceutical composition comprising an androgen
08/29/2007EP1423126B1 Treatment of hyperproliferative conditions of body surfaces
08/29/2007EP1351934B1 Naphthalene derivatives which bind to the ep4 receptor
08/29/2007EP1268431B1 3-cyanoquinolines,3-cyano-1,6-naphthyridines, and 3-cyano-1,7-naphthyridines as protein kinase inhibitors
08/29/2007CN101027061A Pharmaceutical formulations and uses thereof in the treatment of female sexual dysfunction
08/29/2007CN101024089A Function of E4BP4 gene inplantation course and use thereof
08/29/2007CN101024068A Medicine for treating mastitis
08/29/2007CN101024064A Chinese medicine for trecting hyperplasia of mammary glands
08/29/2007CN101024062A Medicine for treating salpingitis tubal obstruction and preparing method
08/29/2007CN101024058A Medicine composition for treating hyperplasia of mammary glands
08/29/2007CN101024047A 3-D incense therapy rod
08/29/2007CN101024028A Medicine composition for treating mammary gland hyperplasia and its extracting preparing method
08/29/2007CN101024015A Caroprocaprae Gutturosae, ginseng, lycium extract for treating scapulohumeral periarthritis, arthromyodynia, impotence, prospermia and sub-health
08/29/2007CN101024007A Micro-emulsion injecta containing houttuynia extract
08/29/2007CN101023992A Medicine for treating mammary gland hyperplasia
08/29/2007CN101023984A Pregnant-woman breast-nursing oil
08/29/2007CN101023973A Extract of polysaccharide of lithospermum erthrorhizon and composition containing same and use thereof
08/29/2007CN100334077C Benzimidazole derivatives and their use as GNRH antagonists
08/29/2007CN100333784C Medicinal capsule for treating gynecological inflammation and its preparation process
08/29/2007CN100333768C Chinese medicine extract for preventing female involutional syndrome or osteoporosis
08/29/2007CN100333767C Medicine for treating male infertility
08/29/2007CN100333761C Chinese medicinal contraception plaster and its preparing process
08/29/2007CN100333747C Medicine for treating pelvic inflammation and its producing method
08/28/2007US7262201 Quinazoline derivatives
08/28/2007US7262187 Substituted oxazolo- and thizaolopyrimidinones as a mitotic kinesin inhibitor
08/28/2007CA2405072C Gel compositions containing metronidazole
08/23/2007WO2007095424A1 Novel tricyclic dihydropyrazines as potassium channel openers
08/23/2007WO2007095286A2 AQUEOUS PHARMACEUTICAL FORMULATIONS OF ERβ SELECTIVE LIGANDS
08/23/2007WO2007094423A1 Human monoclonal antibody capable of binding to human cytomegalovirus, and antigen-binding domain of the antibody
08/23/2007US20070197829 Process for the synthesis and crystalline form agomelatine
08/23/2007US20070197659 Antagonist of the magnesium binding defect as therapeutic agents and methods for treatment of abnormal physiological states
08/23/2007US20070197644 Use of 13-HODE as a regulator of vascular biocompatibility and an inhibitor of cell hyperplasia
08/23/2007US20070197608 Piperazines as oxytocin agonists
08/23/2007US20070197560 cGMP PDE 5 inhibitors for inhalation in the treatment of sexual dysfunction
08/23/2007US20070197551 such as 3-amino-5,6-dimethyl-2-[3-(4-quinolin-2-ylpiperazin-1-yl)propylthio]-3H-thieno[2,3-d]pyrimidin-4-one, having serotonin receptor modulatory activity, used for treating irritable bowel syndrome
08/23/2007US20070197543 Use of derivatives of 2, 5-dihydroxyb enzene-sulphonic acids in the elaboration of a medicinal product to enhance the effect of other drugs used for the treatment of erectile dysfunction
08/23/2007US20070197527 Bicyclic heteroaromatic compounds
08/23/2007CA2642212A1 Novel tricyclic dihydropyrazines as potassium channel openers
08/23/2007CA2641116A1 Aqueous pharmaceutical formulations of er.beta. selective ligands
08/22/2007EP1820861A2 C3B/C4B complement receptor-like molecules and uses thereof
08/22/2007EP1820495A2 Microspheres for active embolization
08/22/2007EP1819726A1 Modulation of ovulation
08/22/2007EP1819722A1 Modulation of ovulation
08/22/2007EP1819355A2 Methods of using chimeric coiled-coil molecule
08/22/2007EP1592431A4 Method of modulating il-6
08/22/2007EP1359920B1 Uses of oral formulations for the treatment of female sexual dysfunction
08/22/2007EP1242009B1 Tissue sensitizing compounds for females with methods and apparatus for the delivery of these compounds